舒芬太尼复合氯诺昔康用于髋关节置换术后静脉自控镇痛的临床观察

目的观察舒芬太尼复合氯诺昔康在髋关节置换术后静脉自控镇痛的效果及不良反应。方法50例全麻下髋关节置换术患者随机分成舒芬太尼组（s组）与芬太尼组（F组），s组：舒芬太尼2懈／b，氯诺昔康40mg，0．9％氯化钠注射液稀释至100ml；F组：芬太尼20肛g／k、氯诺昔康40mg，0．9％氯化钠注射液稀释至100ml。手术结束时连接静脉输注泵镇痛。结果s组术后镇痛满意度评分为（3．0±0．5）分，明显优于F组的（2．7±0．6）分，48h异常出汗和恶心呕吐发生率小于F组（均P〈0．05）。结论舒芬太尼复合氯诺昔康用于髋关节置换术后的静脉自控镇痛的效果优于芬太尼复合氯诺昔康组，不良反应少。

Clinical observation of venous controlled analgesia of sufentanil combined with chlorine for the patients with tolalhip arthroplasty after operation

Objective To observe the effect and adverse reaction of sufentanil combined with lornoxicam in venous controlled analgesia after hip arthroplasty. Methods Fifty patients with general anesthesia orthopaedic hip arthroplasty were randomly divided into sufentanil group (group S) and finnan fluoride group ( F) , group S sufentanil 2μg/kg,lornoxicam 40mg, physiological saline diluted to 100ml canister, Group F fentanyl 20μg/kg, lomoxicam 40mg, physiological saline diluted to 100ml canister. After operation connected intravenous infusion pump analgesia. Results Group S postoperative analgesia was obviously better than the group F,48h abnormal sweating and nausea and vomiting incidence was less than the group F( all P ＜ 0.05). Conclusion The effect of sufentanil combined lornoxicam for hip arthroplasty after intravenous analgesia was better than that of fentanyl combined lornoxicam group and had fewer side effects.